Development of resistance to amphotericin B in Candida lusitaniae infecting a human.


Candida lusitaniae associated with infection in a patient with acute myelogenous leukemia developed resistance to amphotericin B during systemic treatment of the patient. The organism, when isolated initially, was inhibited by 0.31 mug of amphotericin B per ml in yeast nitrogen base agar, but when isolated (20 days later) just antemortem and postmortem… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.